| Subject: | Recall of all Lots of Neupro (rotigotine transdermal system) |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 10 Apr 2008 - 12:00 pm |
| Schwarz Pharma has informed healthcare professionals and patients of the recall of all lots of Neupro, a transdermal delivery system worn on the skin and used to treat early stage Parkinson's disease. Neupro (rotigotine transdermal system) patches will not be available after the end of April 2008.The product is being recalled because of the formation of rotigotine crystals in the patches. When the drug crystallizes, less drug is available to be absorbed through the skin and the efficacy of... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
